Thus these data broaden the known potential of the MCH system for obesity therapeutics to include possibilities for treating other neuropsychological disorders with impulsive behavior as a characteristic (e.g., excessive gambling, drug abuse). The gene discussed is PMCH; the disease is obesity due to melanocortin 4 receptor deficiency.